Long-term modulation of gone expression in epilepsy

Neuroscientist

Volumn 5, Issue 2, 1999, Pages 86-99

  Delorenzo, Robert J ^a   Morris, T Allen ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Epilepsy; Epileptogenesis; Genetic expression; Molecular genetics; Post transcriptional regulation; Transcription factors; Transcriptional regulation

Indexed keywords

CONTROLLED STUDY; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; MOLECULAR GENETICS; REVIEW; SEIZURE; TRANSCRIPTION REGULATION;

EID: 0032962717     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849900500213     Document Type: Review

References (97)

1. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos Publications; 1990.
2. DeLorenzo RJ, Towne AR. Epilepsy. In: Appel SH, editor. Current neurology, vol. 9. Chicago: Year-Book Medical Publishers; 1989, p. 27-76.
3. DeLorenzo RJ. The challenging genetics of epilepsy. Epilepsy Res Suppl 1991;4:3-17.
4. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-406.
5. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998;18:53-55.
6. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995;11:201-203.
7. Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, Berkovic SF, et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997;6:943-947.
8. Lafreniere RG, Rochefort DL, Chretien N, Rommens JM, Cochius JI, Kalviainen R, et al. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 1997;15:298-302.
9. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-1734.
10. Bespalova IN, Adkins S, Pranzatelli M, Burmeister M. Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient. Am J Med Genet 1997;74:467-471.
11. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997;6:577-582.
12. Shimizu S, Nomura K, Ujihara M, Sakamoto K, Shibata H, Suzuki T, et al. An allel-specific abnormal transcript of the heat shock protein 70 gene in patients with major depression. Biochem Biophys Res Commun 1996;219:745-752.
13. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997;88:385-392.
14. Cox GA, Lutz CM, Yang CL, Biemesderfer D, Bronson RT, Fu A, et al. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997;91:139-148.
15. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995;11:126-129.
16. Toth M, Grimsby J, Buzsaki G, Donovan GP. Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat Genet 1995;11:71-75.
17. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 1997;94:14060-14065.
18. Butler LS, Silva AJ, Abeliovich A, Watanabe Y, Tonegawa S, McNamara JO. Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc Natl Acad Sci U S A 1995;92:6852-6855.
19. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995;374:542-546.
20. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 1995;11:45-51.
21. Brusa R, Zimmermann F, Koh DS, Feldmeyer D, Gass P, Seeburg PH, et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995;270:1677-1680.
22. Metrakos K, Metrakos JD. Genetics of convulsive disorders. II. Genetic and electroencephalographic studies in centrecephalic epilepsy. Neurology 1961;11:474-483.
23. Metrakos JD, Metrakos K. Genetics of convulsive disorders. I. Introduction, problems, methods and baselines. Neurology 1960;10:228-240.
24. Greenberg DA, Delgado-Escueta AV, Widelitz H, Sparkes RS, Treiman L, Maldonado HM, et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet 1988;31:185-192.
25. Leppert M, Anderson VE, Quattlebaum T, Leppert M, Anderson VE, Quattlebaum T, et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989;337:647-648.
26. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-29.
27. Noebels JL. Targeting epilepsy genes. Neuron 1996;16:241-244.
28. Lothman EW, Bertram EH, Stringer JL. Functional anatomy of hippocampal seizures. Prog Neurobiol 1991;37:1-82.
29. McNamara JO. Cellular and molecular basis of epilepsy. J Neurosci 1994;14:3413-3425.
30. Jakoi ER, Panchision DM, Gerwin CM, DeLorenzo, RJ. Post-transcriptional regulation of gene expression in hippocampal neurons by glutamate receptor activation. Brain Res 1995;693:124-132.
31. Perlin JB, Gerwin CM, Panchision DM, Vick RS, Jakoi ER, DeLorenzo RJ. Kindling produces long-lasting and selective changes in gene expression of hippocampal neurons. Proc Natl Acad Sci U S A 1993;90:1741-1745.
32. Rice A, Rafiq A, Shapiro SM, Jakoi ER, Coulter DA, DeLorenzo RJ. Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci U S A 1996;93:9665-9669.
33. Tsunashima K, Schwarzer C, Kirchmair E, Sieghart, W, Sperk G. GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy. Neuroscience 1997;80:1019-1032.
34. Tehrani MH, Baumgartner BJ, Liu SC, Barnes EMG. Aberrant expression of GABAA receptor subunits in the tottering mouse: an animal model for absence seizures. Epilepsy Res 1997;28:213-223.
35. A alpha 2 mRNA levels are decreased following induction of spontaneous epileptiform discharges in hippocampal-entorhinal cortical slices. Brain Res 1996;721:111-119.
36. Bellmann R, Widmann R, Olenik C, Meyer DK, Maas D, Marksteiner J, et al. Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem 1991;56:525-530.
37. Marksteiner J, Ortler M, Bellmann R, Sperk G. Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat. Neurosci Lett 1990;112:143-148.
38. Rosen JB, Kim SY, Post RM. Differential regional and time course increases in thyrotropin-releasing hormone, neuropeptide Y and enkephalin mRNAs following an amygdala kindled seizure. Brain Res Mol Brain Res 1994;27:71-80.
39. Akbarian S, Sucher NJ, Bradley D, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996;16:19-30.
40. Vezzani A, Speciale C, Della VF, Tamburin M, Benatti L. Alternative splicing at the C-terminal but not at the N-terminal domain of the NMDA receptor NR1 is altered in the kindled hippocampus. Eur J Neurosci 1995;7:2513-2517.
41. Brines ML, Sundaresan S, Spencer DD, de LN. Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: up-regulation in reorganized epileptogenic hippocampus. Eur J Neurosci 1997;9:2035-2044.
42. Mathern GW, Pretorius JK, Kornblum HI, Mendoza D, Lozada A, Leite JP, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain 1997;120:1937-1959.
43. Grigorenko E, Glazier S, Bell W, Tytell M, Nosel E, Pons T, et al. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy. J Neurol Sci 1997;153:35-45.
44. Prince HK, Conn PJ, Blackstone CD, Huganir RL, Levey AI. Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling. J Neurochem. 1995;64:462-165.
45. Pollard H, Heron A, Moreau J, Ben-Ari Y, Khrestchatisky M. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 1993;57:545-554.
46. Kamphuis W, Hendriksen H, Diegenbach PC, Lopes da Silva FH. N-methyl-D-aspartate and kainate receptor gene expression in hippocampal pyramidal and granular neurons in the kindling model of epileptogenesis. Neuroscience 1995;67:551-559.
47. Lason W, Turchan J, Przewlocka B, Labuz D, Mika J, Przewlocki R. Seizure-related changes in the glutamate R2 and R5 receptor genes expression in the rat hippocampal formation. J Neural Transm 1997;104:125-133.
48. Mello LE, Kohman CM, Tan AM, Finch DM. Lack of Fos-like immunoreactivity after spontaneous seizures or reinduction of status epilepticus by pilocarpine in rats. Neurosci Lett 1996;208:133-137.
49. Sanabria ER, Scorza FA, Bortolotto ZA, Calderazzo-Filho LS, Cavalheiro EA. Disruption of light-induced c-Fos immunoreactivity in the suprachiasmatic nuclei of chronic epileptic rats. Neurosci Lett 1996;216:105-108.
50. Matsuda S, Peng H, Yoshimura H, Wen TC, Fukuda T, Sakanaka M. Persistent c-fos expression in the brains of mice with chronic social stress. Neurosci Res 1996;26:157-170.
51. Gruber B, Greber S, Sperk G. Kainic acid seizures cause enhanced expression of cholecystokinin-octapeptide in the cortex and hippocampus of the rat. Synapse 1993;15:221-228.
52. Bachus SE, Hyde TM, Herman MM, Egan MF, Kleinman JE. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J Psychiatr Res 1997;31:233-256.
53. Mahata SK, Gruber B, Mahata M, Roder C, Fischer-Colbrie R, Sperk G. Kainic acid seizures in the rat: differential expression of chromogranin A, carboxypeptidase H and peptidylglycine alphaamidating monooxigenase in subfields of the hippocampal formation. Acta Neuropathol (Berl) 1993;86:590-595.
54. Bing G, McMillian M, Kim H, Pennypacker K, Feng Z, Qi Q, et al. Long-term expression of the 35,000 mol. wt fos-related antigen in rat brain after kainic acid treatment. Neuroscience 1996;73:1159-1174.
55. Hope BT, Kelz MB, Duman RS, Nestler EJ. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 1994;14:4318-4328.
56. Morris TA, Rice AC, DeLorenzo RJ. Status epilepticus (SE) results in long-term changes in transcription factor binding and expression in a in vivo model of epilepsy [abstract]. Epilepsia 1997;38:124.
57. Bing G, Wilson B, Hudson P, Jin L, Feng Z, Zhang W, et al. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc Natl Acad Sci U S A 1997;94:9422-9427.
58. Garcia ML, Murray KD, Garcia VB, Strehler EE, Isackson PJ. Seizure-induced alterations of plasma membrane calcium ATPase isoforms 1, 2 and 3 mRNA and protein in rat hippocampus. Brain Res Mol Brain Res 1997;45:230-238.
59. Lombardo AJ, Kuzniecky R, Powers RE, Brown GB. Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res 1996;35:84-90.
60. Beldhuis HJ, Everts HG, Van der Zee EA, Luiten PG, Bohus B. Amygdala kindling-induced seizures selectively impair spatial memory. 1. Behavioral characteristics and effects on hippocampal neuronal protein kinase C isoforms. Hippocampus 1992;2:397-409.
61. Wang HY, Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 1996;40:568-575.
62. Magloczky Z, Halasz P, Vajda J, Czirjak S, Freund TF. Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 1997;76:377-385.
63. Montpied P, Winsky L, Dailey JW, Jobe PC , Jacobowitz DM. Alteration in levels of expression of brain calbindin D-28k and calretinin mRNA in genetically epilepsy-prone rats. Epilepsia 1995;36:911-921.
64. Sonnenberg JL, Frantz GD, Lee S, Heick A, Chu C, Tobin AJ, et al. Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures. Brain Res Mol Brain Res 1991;9:179-190.
65. Iacopino AM, Christakos S. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci U S A 1990;87:4078-4082.
66. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52:258-266.
67. Ribak CE, Lauterbom JC, Navetta MS, Gall CM. The inferior colliculus of GEPRs contains greater numbers of cells that express glutamate decarboxylase (GAD67) mRNA. Epilepsy Res 1993;14:105-113.
68. Schwarzer C, Sperk G. Hippocampal granule cells express glutamic acid decarboxylase-67 after limbic seizures in the rat. Neuroscience 1995;69:705-709.
69. Wasterlain CG, Farber DB. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc Natl Acad Sci U S A 1984;81:1253-1257.
70. Goldenring JR, Wasterlain CG, Oestreicher AB, de GP, Farber DB, Glaser G, DeLorenzo RJ. Kindling induces a long-lasting change in the activity of a hippocampal membrane calmodulin-dependent protein kinase system. Brain Res 1986;377:47-53.
71. Churn SB, Sankaran B, Haley BE, DeLorenzo RJ. Ischemic brain injury selectively alters ATP binding of calcium and calmodulin-dependent protein kinase II. Biochem Biophys Res Commun 1993;193:934-940.
72. Churn SB, Anderson WW, DeLorenzo RJ. Exposure of hippocampal slices to magnesium-free medium produces epileptiform activity and simultaneously decreases calcium and calmodulin-dependent protein kinase II activity. Epilepsy Res 1991;9:211-217.
73. Morgan JI, Cohen DR, Hempstead JL, Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 1987;237:192-197.
74. Dragunow M, Robertson HA. Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 1987;329:441-442.
75. Morgan JI, Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci 1991;12:343-349.
76. Hughes P, Dragunow M. Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons. Brain Res Mol Brain Res 1994;24:166-178.
77. Li X, Song L, Kolasa K, Jope RS. Adrenalectomy potentiates immediate early gene expression in rat brain. J Neurochem 1992;58:2330-2333.
78. Wessel TC, Joh TH, Volpe BT. In situ hybridization analysis of c-fos and c-jun expression in the rat brain following transient forebrain ischemia. Brain Res 1991;567:231-240.
79. Dragunow M, Robertson HA. Brain injury induces c-fos protein(s) in nerve and glial-like cells in adult mammalian brain. Brain Res 1988;455:295-299.
80. Honkaniemi J, Sagar SM, Pyykonen I, Hicks KJ, Sharp FR. Focal brain injury induces multiple immediate early genes encoding zinc finger transcription factors. Brain Res Mol Brain Res 1995;28:157-163.
81. McNamara JO. Kindling model of epilepsy. Adv Neurol 1986;44:303-318.
82. Olney JW, Rhee V, Ho OL. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 1974;77:507-512.
83. Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, et al. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 1993;34:985-995.
84. Gibbs JW, Shumate MD, Coulter DA. Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J Neurophysiol 1997;77:1924-1938.
85. Kapur J, Lothman EW, DeLorenzo RJ. Loss of GABAA receptors during partial status epilepticus. Neurology 1994;44:2407-2408.
86. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Physiological and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J Neurophysiol 1997;77:2139-2152.
87. Bronstein JM, Farber DB, Wasterlain CG. Regulation of type-II calmodulin kinase: functional implications. Brain Res Brain Res Rev 1993;18:135-147.
88. Churn SB. Multifunctional calcium and calmodulin-dependent kinase II in neuronal function and disease. Adv Neuroimmunol 1995;5:241-259.
89. Bronstein JM, Micevych P, Popper P, Huez G, Farber DB, Wasterlain CG. Long-lasting decreases of type II calmodulin kinase expression in kindled rat brains. Brain Res 1992;584:257-260.
90. Sombati S, DeLorenzo RJ. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J Neurophysiol 1995;73:1706-1711.
91. Cain DP. LTP, NMDA, genes and learning. Curr Opin Neurobiol 1997;7:235-242.
92. Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 1998;782:240-247.
93. Ghosh D. A relational database of transcription factors. Nucleic Acids Res 1990;18:1749-1756.
94. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995;268:239-247.
95. Kochan LD, Churn SB, Rice AC, DeLorenzo RJ. Status epilepticus produces acute and long-term alterations in CaM Kinase II activity. Soc Neurosci Abstr 1997;23:2159.
96. A receptor subunit expression in association with the induction of epileptogenesis in an in vitro model of epilepsy. Neurology 1996;46:357A.
97. Churn SB, Kochan LD, DeLorenzo RJ. Status epilepticus results in acute inhibition of CaM Kinase II activity and benzodiazepine binding in cortical tissue. Soc Neurosci Abstr 1997;23:2159.